Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

31.33
Delayed Data
As of 4:02pm ET
 -0.47 / -1.48%
Today’s Change
25.55
Today|||52-Week Range
35.04
+14.68%
Year-to-Date
Company News for March 28, 2017
10:54am / Zacks.com - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer
Mar 27 / TheStreet.com - Paid Partner Content
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar 20 / Zacks.com - Paid Partner Content
AstraZeneca's Lung Cancer Drug Tagrisso Approved in China
Mar 27 / Zacks.com - Paid Partner Content
AstraZeneca (AZN): Should Value Investors Pick this Stock?
Mar 17 / Zacks.com - Paid Partner Content
Primecap Sells NVIDIA, Microsoft, Union Pacific
Mar 23 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Exp...
Mar 17 / Zacks.com - Paid Partner Content
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
Inovio (INO) Q4 Loss Wider than Expected; Shares Decline
Mar 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.80
Today’s open31.58
Day’s range31.33 - 31.61
Volume4,575,772
Average volume (3 months)6,819,234
Market cap$80.5B
Dividend yield4.47%
Data as of 4:02pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+23.59%
Earnings growth (this year)-14.21%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-7.37%
P/E ratio22.7
Price/Sales3.03
Price/Book5.36

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+1.15+0.48%
ABTAbbott Laboratories0.000.00%
BMYBristol-Myers Squibb+0.16+0.29%
LLYEli Lilly and Co+0.51+0.61%
Data as of 4:01pm ET, 03/28/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$22.8B
Annual profit (last year)$3.5B
Net profit margin15.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts


Search for Jobs